Intuitive Surgical Q1 2026 Earnings Beat Wall Street Estimates
Intuitive Surgical (NASDAQ:ISRG) reported strong first-quarter 2026 results, beating Wall Street estimates on both revenue and earnings. The stock has an upside potential of 35.5%, according to analysts, placing it among the best agentic AI stocks to buy.
Key Numbers
Intuitive Surgical (NASDAQ:ISRG) reported strong first-quarter 2026 results, exceeding Wall Street projections in both revenue and earnings. Analysts see an upside potential of 35.5% for the stock, reinforcing its position as one of the best agentic AI stocks to buy right now.
Key Financial Results
| Metric | Actual | Estimate |
|---|---|---|
| Revenue | $2.1 billion | $1.9 billion |
| EPS | $1.62 | $1.45 |
Year-over-year comparisons were not provided.
Highlights from the Report
The company attributed the strong performance to increased demand for its da Vinci surgical systems, particularly in international markets. Expansion of AI integration in surgical procedures also contributed.
Forward Guidance
No specific numerical guidance was provided for the next quarter, but the company indicated continued growth in demand for robotic surgery solutions.
Stock Impact
The stock edged higher following the announcement, with analysts maintaining buy ratings due to growth prospects.
What This Means for Investors
Intuitive Surgical's strong performance demonstrates its growth potential in healthcare, especially with increasing adoption of AI. However, investors should consider risks such as the stock's high valuation.
Frequently Asked Questions
Found this useful? Share it